France's Bold Move: State Coverage for Breakthrough Obesity Drugs
Published on: May 28, 2026, 3:49 p.m. | Source: Devdiscourse
France will start reimbursing weight-loss drugs for severely obese patients, becoming the first EU nation to do so. These drugs, Novo Nordisk's Wegovy and Eli Lilly's Mounjaro, are part of the anti-obesity treatment boom. The initiative reflects France's commitment to addressing obesity as a public health issue.
